Abiopharma

Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026

Holdings of interested parties/officers as of 31.3.26

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

Sidus Space Announces Pricing of $58.5 Million Registered Direct Offering of Class A Common Stock

BLD Stock Alert: Halper Sadeh LLC is Investigating Whether TopBuild Corp. is Obtaining a Fair Price for its Shareholders

QXO Stock Alert: Halper Sadeh LLC is Investigating Whether QXO, Inc. is Obtaining a Fair Price for its Shareholders

AST SpaceMobile Addresses Today’s Orbital Launch of BlueBird 7 on the New Glenn Launch Vehicle

Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting